Jonathan H. Clarke

2.5k total citations
47 papers, 2.0k citations indexed

About

Jonathan H. Clarke is a scholar working on Molecular Biology, Cell Biology and Biomedical Engineering. According to data from OpenAlex, Jonathan H. Clarke has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 25 papers in Cell Biology and 13 papers in Biomedical Engineering. Recurrent topics in Jonathan H. Clarke's work include Cellular transport and secretion (22 papers), Protein Kinase Regulation and GTPase Signaling (16 papers) and Biofuel production and bioconversion (13 papers). Jonathan H. Clarke is often cited by papers focused on Cellular transport and secretion (22 papers), Protein Kinase Regulation and GTPase Signaling (16 papers) and Biofuel production and bioconversion (13 papers). Jonathan H. Clarke collaborates with scholars based in United Kingdom, Netherlands and South Sudan. Jonathan H. Clarke's co-authors include Robin F. Irvine, Nullin Divecha, Clive S. D’Santos, Harry J. Gilbert, G. P. Hazlewood, Jonathan R. Halstead, Andrew J. Letcher, Jane E. Rixon, Keith Davidson and Geoffrey P. Hazlewood and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Cell and The Journal of Comparative Neurology.

In The Last Decade

Jonathan H. Clarke

46 papers receiving 2.0k citations

Peers

Jonathan H. Clarke
Antonio Ciruela United Kingdom
Patricie Burda Switzerland
Stephen R. Hamilton United States
Oleh Stasyk Ukraine
Claude A. Jakob Switzerland
Antonio Ciruela United Kingdom
Jonathan H. Clarke
Citations per year, relative to Jonathan H. Clarke Jonathan H. Clarke (= 1×) peers Antonio Ciruela

Countries citing papers authored by Jonathan H. Clarke

Since Specialization
Citations

This map shows the geographic impact of Jonathan H. Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan H. Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan H. Clarke more than expected).

Fields of papers citing papers by Jonathan H. Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan H. Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan H. Clarke. The network helps show where Jonathan H. Clarke may publish in the future.

Co-authorship network of co-authors of Jonathan H. Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan H. Clarke. A scholar is included among the top collaborators of Jonathan H. Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan H. Clarke. Jonathan H. Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGeachan, Robert I., S. Meftah, Jamie Rose, et al.. (2024). p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003. Acta Neuropathologica. 147(1). 7–7. 15 indexed citations
2.
Rooney, Timothy P. C., Henriëtte M. G. Willems, Christopher Green, et al.. (2023). The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K). RSC Medicinal Chemistry. 14(10). 2035–2047. 1 indexed citations
3.
Willems, Henriëtte M. G., Simon Edwards, Christopher Green, et al.. (2023). Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor. RSC Medicinal Chemistry. 14(5). 934–946. 5 indexed citations
4.
Al‐Ramahi, Ismael, Sai Srinivas Panapakkam Giridharan, Yu‐Chi Chen, et al.. (2017). Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein. eLife. 6. 51 indexed citations
5.
Clarke, Jonathan H., et al.. (2015). Phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ), a lipid signalling enigma. Advances in Biological Regulation. 61. 47–50. 7 indexed citations
6.
Clarke, Jonathan H., et al.. (2014). Exploring phosphatidylinositol 5-phosphate 4-kinase function. Advances in Biological Regulation. 57. 193–202. 42 indexed citations
7.
Clarke, Jonathan H., Piers C. Emson, & Robin F. Irvine. (2009). Distribution and neuronal expression of phosphatidylinositol phosphate kinase IIγ in the mouse brain. The Journal of Comparative Neurology. 517(3). 296–312. 23 indexed citations
8.
Clarke, Jonathan H., Michael Wang, & Robin F. Irvine. (2009). Localization, regulation and function of Type II phosphatidylinositol 5-phosphate 4-kinases. Advances in Enzyme Regulation. 50(1). 12–18. 30 indexed citations
9.
Clarke, Jonathan H., Piers C. Emson, & Robin F. Irvine. (2008). Localization of phosphatidylinositol phosphate kinase IIγ in kidney to a membrane trafficking compartment within specialized cells of the nephron. American Journal of Physiology-Renal Physiology. 295(5). F1422–F1430. 55 indexed citations
10.
Richardson, Jonathan P., Jonathan H. Clarke, Katherine A. Hinchliffe, & Robin F. Irvine. (2007). Type II PtdInsP kinases: location, regulation and function. Biochemical Society Symposia. 74(1). 149–149. 20 indexed citations
11.
Clarke, Jonathan H., et al.. (2005). Effects of lipid kinase expression and cellular stimuli on phosphatidylinositol 5‐phosphate levels in mammalian cell lines. FEBS Letters. 579(13). 2868–2872. 40 indexed citations
12.
Clarke, Jonathan H.. (2003). Lipid Signalling: Picking Out The PIPs. Current Biology. 13(20). R815–R817. 17 indexed citations
13.
Clarke, Jonathan H., Andrew J. Letcher, Clive S. D’Santos, et al.. (2001). Inositol lipids are regulated during cell cycle progression in the nuclei of murine erythroleukaemia cells. Biochemical Journal. 357(3). 905–905. 123 indexed citations
14.
D’Santos, Clive S., Jonathan H. Clarke, R.F. Irvine, & Nullin Divecha. (1999). Nuclei contain two differentially regulated pools of diacylglycerol. Current Biology. 9(8). 437–440. 75 indexed citations
15.
Fontes, C.M.G.A., Jonathan H. Clarke, G. P. Hazlewood, et al.. (1998). Identification of tandemly repeated type VI cellulose-binding domains in an endoglucanase from the aerobic soil bacterium Cellvibrio mixtus. Applied Microbiology and Biotechnology. 49(5). 552–559. 16 indexed citations
16.
Fontes, C.M.G.A., Jonathan H. Clarke, G. P. Hazlewood, et al.. (1997). Possible roles for a non-modular, thermostable and proteinase-resistant cellulase from the mesophilic aerobic soil bacterium Cellvibrio mixtus. Applied Microbiology and Biotechnology. 48(4). 473–479. 24 indexed citations
17.
Rixon, Jane E., et al.. (1996). Do the non-catalytic polysaccharide-binding domains and linker regions enhance the biobleaching properties of modular xylanases?. Applied Microbiology and Biotechnology. 46(5-6). 514–520. 14 indexed citations
18.
Clarke, Jonathan H., Keith Davidson, Harry J. Gilbert, C.M.G.A. Fontes, & Geoffrey P. Hazlewood. (1996). A modular xylanase from mesophilicCellulomonas fimicontains the same cellulose-binding and thermostabilizing domains as xylanases from thermophilic bacteria. FEMS Microbiology Letters. 139(1). 27–35. 46 indexed citations
19.
Clarke, Jonathan H., et al.. (1991). Multiple xylanases ofCellulomona fimiare encoded by distinct genes. FEMS Microbiology Letters. 83(3). 305–309. 30 indexed citations
20.
Hazlewood, Geoffrey P., Keith Davidson, Jonathan H. Clarke, et al.. (1990). Endoglucanase E, produced at high level in Escherichia coli as a lacZ′ fusion protein, is part of the Clostridium thermocellum cellulosome. Enzyme and Microbial Technology. 12(9). 656–662. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026